{"name": "Discovery Laboratories",
 "permalink": "discovery-laboratories",
 "crunchbase_url": "http://www.crunchbase.com/company/discovery-laboratories",
 "homepage_url": "http://www.discoverylabs.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "bd@discoverylabs.com",
 "phone_number": "215.488.9300",
 "description": "",
 "created_at": "Thu Sep 16 04:41:33 UTC 2010",
 "updated_at": "Mon Jun 10 10:39:52 UTC 2013",
 "overview": "\u003Cp\u003EDiscovery Laboratories, Inc. is a biotechnology company developing KL4 surfactant therapies for respiratory diseases. Surfactants are produced naturally in the lungs and are essential for breathing. Discovery Labs\u00e2\u20ac\u2122 novel proprietary KL4 surfactant technology produces a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant and is being developed in liquid, aerosol or lyophilized formulations. In addition, Discovery Labs\u00e2\u20ac\u2122 proprietary capillary aerosolization technology produces a dense aerosol, with a defined particle\nsize that is capable of potentially delivering aerosolized KL4 surfactant to the deep lung without the complications currently associated with liquid surfactant administration. Discovery Labs believes that its proprietary technology platform makes it possible, for the first time, to develop a significant pipeline of surfactant products to address a variety of respiratory diseases for which there frequently are few or no approved therapies.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       41],
      "assets/images/resized/0010/1944/101944v1-max-150x150.png"],
     [[250,
       68],
      "assets/images/resized/0010/1944/101944v1-max-250x250.png"],
     [[383,
       105],
      "assets/images/resized/0010/1944/101944v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "W.",
      "last_name": "Thomas Amick",
      "permalink": "w-thomas-amick-2",
      "image": null}},
   {"is_past": false,
    "title": "Board of Directors",
    "person":
     {"first_name": "Bruce",
      "last_name": "A. Peacock",
      "permalink": "bruce-a-peacock",
      "image": null}},
   {"is_past": true,
    "title": "President \u0026 CFO",
    "person":
     {"first_name": "John",
      "last_name": "G. Cooper",
      "permalink": "john-g-cooper",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$30.5k",
 "funding_rounds":
  [{"round_code": "seed",
    "source_url": "http://www.sec.gov/Archives/edgar/data/946486/000094648613000002/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 18450.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 3,
    "funded_day": 15,
    "investments":
     []},
   {"round_code": "seed",
    "source_url": "http://www.sec.gov/Archives/edgar/data/946486/000094648613000003/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 12000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 6,
    "funded_day": 5,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "2600 Kelly Road",
    "address2": "Suite 100",
    "zip_code": "18976",
    "city": "Warrington",
    "state_code": "PA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo":
  {"valuation_amount": null,
   "valuation_currency_code": "USD",
   "pub_year": null,
   "pub_month": null,
   "pub_day": null,
   "stock_symbol": "NASDAQ:DSCO"},
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}